These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 1373475
1. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis. Salvati F, Strippoli P, Barchetti M, Scatizzi A. Nephron; 1992; 60(3):371. PubMed ID: 1373475 [No Abstract] [Full Text] [Related]
2. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis]. Hanicki Z, Sułowicz W, Stepniewski M, Kuźniewski M, Kraśniak A, Kopeć J, Cieszkowska U, Solarska K. Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757 [Abstract] [Full Text] [Related]
3. Hemoglobin F levels in end-stage renal disease patients after correction of anemia with erythropoietin. Sikole A, Efremov DG, Dimovski A, Efremov GD, Polenakovic M. Nephron; 1993 Jun; 65(3):482-4. PubMed ID: 7507224 [No Abstract] [Full Text] [Related]
4. Recombinant human erythropoietin stimulates synthesis of fetal haemoglobin in haemodialysed patients with anaemia due to end-stage kidney. Hanicki Z, Sułowicz W, Stepniewski M, Kuźniewski M, Kraśniak A, Kopeć J, Cieszkowska U, Stolarska K. Contrib Nephrol; 1990 Jun; 87():11-4. PubMed ID: 1709603 [No Abstract] [Full Text] [Related]
5. Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus. Nakatsuka K, Hino M, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H. Diabetes Care; 1990 Nov; 13(11):1130-1. PubMed ID: 2261828 [No Abstract] [Full Text] [Related]
6. Reticulocyte count used to assess recombinant human erythropoietin sensitivity in hemodialysis patients. Tatsumi N, Kojima K, Tsuda I, Yamagami S, Itoh Y, Tanaka H. Contrib Nephrol; 1990 Nov; 82():41-8. PubMed ID: 2093525 [No Abstract] [Full Text] [Related]
10. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis]. Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G. Pediatr Med Chir; 1991 Nov; 13(5):475-7. PubMed ID: 1788107 [Abstract] [Full Text] [Related]
13. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial. Beiraghdar F, Panahi Y, Einollahi B, Nemati E, Ghadiani MH, Sahebkar A, Maghsoudi N, Marzony ET. Clin Lab; 2012 Nov; 58(7-8):737-45. PubMed ID: 22997974 [Abstract] [Full Text] [Related]